Target Company Overview
Halo X-ray Technologies (HALO) was founded in 2012 through a collaboration between Nottingham Trent University and Cranfield University. The company's innovative platform technology allows for the scanning and identification of materials at inspection speeds that are viable for commercial use across multiple sectors. This cutting-edge technology is rooted in extensive research conducted by Professors Paul Evans and Kieth Rodgers. Notably, new systems leveraging this technology are under development specifically for aviation security, aiming to accurately identify restricted materials.
HALO has pioneered a cost-effective and potentially disruptive additive technology designed to enhance passenger safety while providing significant commercial advantages within the airport security industry.
Industry Overview
The airport security industry in the UK is at a pivotal moment, faced with the dual challenge of ensuring passenger safety while maximizing operational efficiency. With the rise of global air travel, there is an increasing demand for advanced security technologies that can keep pace with the growing volume of passengers and luggage without causing significant delays.
In response to these challenges, regulatory bodies and airport authorities in the UK are actively seeking solutions that not only enhance safety measures but also streamline their security processes. Consequently, this market is witnessing considerable investment in emerging technologies that can provide innovative approaches to scanning and material identification.
The demand for rapid, unobtrusive security solutions is poised to grow further as travelers become more accustomed to sophisticated technology. This growing acceptance presents a unique opportunity for innovators like HALO to gain traction in an industry that is traditionally cautious about adopting new methods.
Furthermore, the emphasis on passenger experience alongside security is becoming increasingly critical. Solutions that can improve security without compromising the fluidity of passenger movement through airports are highly sought after, presenting a ripe environment for HALO's offerings.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Rationale Behind the Deal
The recent investment from Midven is instrumental for HALO's goal of fully commercializing its flagship product. The funding will facilitate a shift in focus toward business development and customer engagement, which are vital for scaling the company's operations. This investment aligns perfectly with Rob Evans of Cranfield University’s vision for successful technology transfer from university research environments to the marketplace.
With this financial injection, HALO anticipates expanding its workforce, expecting to create 20 engineering and software development roles over the next three years, which is crucial for meeting the anticipated demand for its technology.
Investor Information
Midven is a prominent Birmingham-based venture capital firm with over 25 years of experience in supporting small and medium enterprises (SMEs) in the Midlands region. They have invested more than £60 million within the area and secured an additional £200 million in co-investments for their portfolio companies.
Currently, Midven is managing a £35 million equity allocation from the Midlands Engine Investment Fund (MEIF), which aims to inject between £250,000 and £2 million into high-growth opportunities and support the ambitions of aspiring entrepreneurs throughout the Midlands.
View of Dealert
The deal between HALO X-ray Technologies and Midven appears to be a strategic investment with significant potential. Given HALO's innovative approach to airport security challenges, this funding will likely accelerate the development and commercialization of their technology, tapping into a fast-evolving industry.
The focus on creating specialized jobs indicates a commitment to long-term growth, with the capability to bring forward their product offerings in a sector that is ever-increasing in importance. Moreover, with regulatory pressures to enhance security technology, HALO finds itself well-positioned to capitalize on emerging opportunities.
However, the success of this investment will greatly depend on HALO's execution capabilities in transitioning from a research-focused entity to a commercially viable business. Their ability to effectively engage with clients and adapt to market feedback will also be essential as they scale up operations.
Overall, this investment represents a promising move towards not only advancing safety in aviation but potentially leading to wider applications of their technology across various industries, making it a potentially lucrative venture.
Similar Deals
UK Innovation & Science Seed Fund (UKI2S), Foresight Group, Blackfinch Ventures → Spaceflux
2025
UK Innovation and Science Seed Fund (UKI2S) → Helix Technologies
2021
Cambridge Innovation Capital, SV Health Investors’ Dementia Discovery Fund, M Ventures, Pfizer Ventures → TRIMTECH Therapeutics
2025
Midven
invested in
Halo X-ray Technologies
in 2023
in a Seed Stage deal
Disclosed details
Transaction Size: $0M
Equity Value: $0M